Beautyman Elizabeth MD is categorized under Hematologists in New York City, NY and active since 1985.
Beautyman Elizabeth MD was established in 1985, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Elizabeth Beautyman at the company’s single location by writing to 315 West 57th St # 304, New York City, New York NY 10019 or by phoning (212) 755-0285. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Beautyman Elizabeth MD |
| Contact Person: | Elizabeth Beautyman |
| Address: | 315 West 57th St # 304, New York City, New York 10019 |
| Phone Number: | (212) 755-0285 |
| Website Address: | drbeautyman.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1985 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hematologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Beautyman Elizabeth MD was started in 1985 to provide professional Hematologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Elizabeth Beautyman for inquiries that concern Beautyman Elizabeth MD by calling the company number (212) 755-0285, as your correspondence is most welcome. Additionally, the physical location of the single location of Beautyman Elizabeth MD can be found at the coordinates 40.766893,-73.983287 as well as the street address 315 West 57th St # 304 in New York City, New York 10019.
For its online presence, you may visit Beautyman Elizabeth MD’s website at drbeautyman.com and engage with its social media outlets through on Twitter and on Facebook.